CORRESPONDENCE

CDK4/6 Inhibitors in Estrogen Receptor–Low Breast Cancer

  • Ergun, Yakup MD
  • Department of Medical Oncology, Bower Hospital, Diyarbakır, Turkey
Yakup Ergun, MD, Corresponding author: Yakup Ergun, MD; Social Media Handle: @dr_yakupergun; e-mail: [email protected].
Journal of Clinical Oncology, August 28, 2025. | DOI: 10.1200/JCO-25-00836

Corresponding Article

Reply to: “Rethinking Treatment Priorities in Estrogen Receptor–Low Breast Cancer” and “CDK4/6 Inhibitors in Estrogen Receptor–Low Breast Cancer”

  • Goetz, Matthew P. MD,
  • Choong, Grace M. MD
  • Hoskin, Tanya L. MS
  • Boughey, Judy C. MD
  • Wijayawardana, Sameera R. PhD
  • Ingle, James N. MD
Journal of Clinical Oncology, August 28, 2025. | DOI: 10.1200/JCO-25-01688
Copyright © 2025 by American Society of Clinical Oncology